NASDAQ:NRXP | Free Cash Flow | NRX Pharmaceuticals, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$4.3M
2025-12-31-$3.71M
2025-03-31-$3.48M
2024-12-31-$2.1M
2024-03-31-$3.67M
2023-12-31-$3.19M
2023-03-31-$6.09M
2022-12-31-$8.32M
2022-03-31-$10.38M
2021-12-31-$11.28M
2021-03-31-$3.02M
2020-12-31-$406,706.00
2020-03-31-$76,434.00
2019-12-31-$262,074.00
2019-03-31-$297,696.00
2018-12-31-$70,884.00
2018-03-31-$197,817.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$14.11M
2024-12-31-$10.64M
2023-12-31-$21.66M
2022-12-31-$39.76M
2021-12-31-$37.7M
2020-12-31-$2.27M
2019-12-31-$792,731.00
2018-12-31-$473,187.00